As CCR10 appears to function as a linkage between TNF stimulation and downstream PI3K/Akt pathway activation, CCR10 may show promise as a potential therapeutic target for inflammation-driven HCC. The gene discussed is AKT1; the disease is hepatocellular carcinoma.